274 related articles for article (PubMed ID: 29630902)
1. Repurposing and repositioning neurosteroids in the treatment of traumatic brain injury: A report from the trenches.
Stein DG; Sayeed I
Neuropharmacology; 2019 Mar; 147():66-73. PubMed ID: 29630902
[TBL] [Abstract][Full Text] [Related]
2. Drug Repurposing in Neurological Disorders: Implications for Neurotherapy in Traumatic Brain Injury.
Shakkour Z; Habashy KJ; Berro M; Takkoush S; Abdelhady S; Koleilat N; Eid AH; Zibara K; Obeid M; Shear D; Mondello S; Wang KK; Kobeissy F
Neuroscientist; 2021 Dec; 27(6):620-649. PubMed ID: 33089741
[TBL] [Abstract][Full Text] [Related]
3. Progesterone neuroprotection: The background of clinical trial failure.
Schumacher M; Denier C; Oudinet JP; Adams D; Guennoun R
J Steroid Biochem Mol Biol; 2016 Jun; 160():53-66. PubMed ID: 26598278
[TBL] [Abstract][Full Text] [Related]
4. Development of a novel progesterone analog in the treatment of traumatic brain injury.
Sayeed I; Wali B; Guthrie DB; Saindane MT; Natchus MG; Liotta DC; Stein DG
Neuropharmacology; 2019 Feb; 145(Pt B):292-298. PubMed ID: 30222982
[TBL] [Abstract][Full Text] [Related]
5. Modulation of traumatic brain injury using progesterone and the role of glial cells on its neuroprotective actions.
Feeser VR; Loria RM
J Neuroimmunol; 2011 Aug; 237(1-2):4-12. PubMed ID: 21777982
[TBL] [Abstract][Full Text] [Related]
6. Progesterone in the clinical treatment of acute traumatic brain injury.
Stein DG; Wright DW
Expert Opin Investig Drugs; 2010 Jul; 19(7):847-57. PubMed ID: 20486864
[TBL] [Abstract][Full Text] [Related]
7. Catecholaminergic based therapies for functional recovery after TBI.
Osier ND; Dixon CE
Brain Res; 2016 Jun; 1640(Pt A):15-35. PubMed ID: 26711850
[TBL] [Abstract][Full Text] [Related]
8. CNS repurposing - Potential new uses for old drugs: Examples of screens for Alzheimer's disease, Parkinson's disease and spasticity.
Parsons CG
Neuropharmacology; 2019 Mar; 147():4-10. PubMed ID: 30165077
[TBL] [Abstract][Full Text] [Related]
9. Does progesterone have neuroprotective properties?
Stein DG; Wright DW; Kellermann AL
Ann Emerg Med; 2008 Feb; 51(2):164-72. PubMed ID: 17588708
[TBL] [Abstract][Full Text] [Related]
10. Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats.
Frau R; Bortolato M
Neuropharmacology; 2019 Mar; 147():55-65. PubMed ID: 29907425
[TBL] [Abstract][Full Text] [Related]
11. Progesterone: therapeutic opportunities for neuroprotection and myelin repair.
Schumacher M; Guennoun R; Stein DG; De Nicola AF
Pharmacol Ther; 2007 Oct; 116(1):77-106. PubMed ID: 17659348
[TBL] [Abstract][Full Text] [Related]
12. Drug Repurposing: Promises of Edaravone Target Drug in Traumatic Brain Injury.
Shakkour Z; Issa H; Ismail H; Ashekyan O; Habashy KJ; Nasrallah L; Jourdi H; Hamade E; Mondello S; Sabra M; Zibara K; Kobeissy F
Curr Med Chem; 2021; 28(12):2369-2391. PubMed ID: 32787753
[TBL] [Abstract][Full Text] [Related]
13. Repurposing available drugs for neurodevelopmental disorders: The fragile X experience.
Tranfaglia MR; Thibodeaux C; Mason DJ; Brown D; Roberts I; Smith R; Guilliams T; Cogram P
Neuropharmacology; 2019 Mar; 147():74-86. PubMed ID: 29792283
[TBL] [Abstract][Full Text] [Related]
14. Neuropharmacology in traumatic brain injury: from preclinical to clinical neuroprotection?
Lerouet D; Marchand-Leroux C; Besson VC
Fundam Clin Pharmacol; 2021 Jun; 35(3):524-538. PubMed ID: 33527472
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the neurotherapeutic potential of a water-soluble progesterone analog after traumatic brain injury in rats.
Wali B; Sayeed I; Guthrie DB; Natchus MG; Turan N; Liotta DC; Stein DG
Neuropharmacology; 2016 Oct; 109():148-158. PubMed ID: 27267687
[TBL] [Abstract][Full Text] [Related]
16. Progesterone in the treatment of acute traumatic brain injury: a clinical perspective and update.
Stein DG
Neuroscience; 2011 Sep; 191():101-6. PubMed ID: 21497181
[TBL] [Abstract][Full Text] [Related]
17. Repurposing sex steroids and related drugs as potential treatment for Parkinson's disease.
Bourque M; Morissette M; Di Paolo T
Neuropharmacology; 2019 Mar; 147():37-54. PubMed ID: 29649433
[TBL] [Abstract][Full Text] [Related]
18. A clinical/translational perspective: can a developmental hormone play a role in the treatment of traumatic brain injury?
Stein DG
Horm Behav; 2013 Feb; 63(2):291-300. PubMed ID: 22626570
[TBL] [Abstract][Full Text] [Related]
19. Neurosteroids and Ischemic Stroke: Progesterone a Promising Agent in Reducing the Brain Injury in Ischemic Stroke.
Andrabi SS; Parvez S; Tabassum H
J Environ Pathol Toxicol Oncol; 2017; 36(3):191-205. PubMed ID: 29283333
[TBL] [Abstract][Full Text] [Related]
20. Neurotherapeutic capacity of P7C3 agents for the treatment of Traumatic Brain Injury.
Blaya MO; Wasserman JM; Pieper AA; Sick TJ; Bramlett HM; Dietrich WD
Neuropharmacology; 2019 Feb; 145(Pt B):268-282. PubMed ID: 30236963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
